SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Panacos Pharmaceuticals (PANC) -- Ignore unavailable to you. Want to Upgrade?

To: idos who wrote (43)12/27/2007 6:23:50 PM
From: tuck  Read Replies (1) | Respond to of 53
 
>>Stock Rating Reiterations Closing Update: PANC
Last update: 12/27/2007 4:22:22 PM

Rating reiterations for December 27 from Briefing.com:

Company Symbol Brokerage Firm Reiterations

Panacos Pharma PANC Punk, Ziegel & Co Buy <<

Can't find any text to go with the teaser. Optimism that the oral versions' problems will be solved and that the PK will look better? Who knows. The stock is actually off a penny after hours.

Cheers, Tuck



To: idos who wrote (43)3/5/2008 10:17:41 AM
From: idos  Respond to of 53
 
They have correlated viral load reductions on bevirimat with polymorphisms within the GAG sequence of the HIV genome. Sounds reasonable but correlation is not complete. They initiate Phase II trial to prove the GAG polymorphism response hypothesis.

And Bear Stearns upgrades from Peer Perform to Outperform.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News